High Point Advisor Group LLC Tenaya Therapeutics, Inc. Transaction History
High Point Advisor Group LLC
- $1.84 Billion
- Q2 2025
A detailed history of High Point Advisor Group LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, High Point Advisor Group LLC holds 51,500 shares of TNYA stock, worth $99,910. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,500
Previous 51,500
-0.0%
Holding current value
$99,910
Previous $29,000
6.9%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding TNYA
# of Institutions
95Shares Held
37MCall Options Held
91.4KPut Options Held
50.3K-
Column Group LLC San Francisco, CA9.4MShares$18.2 Million8.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.76MShares$9.23 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$7.9 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.26MShares$4.38 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.84MShares$3.58 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $80.2M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...